Molecular cloning and characterization of canine fractalkine and its receptor CX 3CR1

Veterinary Immunology and Immunopathology

Volumn 145, Issue 1-2, 2012, Pages 100-109

  Maeda, Shingo ^a   Ohno, Koichi ^a   Nakashima, Ko ^a   Fukushima, Kenjiro ^a   Tsukamoto, Atsushi ^a   Suzuki, Hiyoshi ^a   Fujiwara, Aki ^a   Goto Koshino, Yuko ^a   Fujino, Yasuhito ^a   Tsujimoto, Hajime ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

CDNA cloning; Chemokine; CX 3CL1; CX 3CR1; Dog

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; FRACTALKINE; MESSENGER RNA;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; CELL STRAIN HEK293; CHEMOTAXIS; CONTROLLED STUDY; CROSS REACTION; HUMAN; HUMAN CELL; LYMPH NODE; MESENTERY LYMPH NODE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS; POPLITEAL LYMPH NODE; PROTEIN DOMAIN; PROTEIN EXPRESSION; SKELETAL MUSCLE; SMALL INTESTINE; SPINAL CORD; STOMACH;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; BASE SEQUENCE; CHEMOKINE CX3CL1; CLONING, MOLECULAR; CROSS REACTIONS; DOGS; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; MICE; MOLECULAR SEQUENCE DATA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CYTOKINE; RECEPTORS, HIV; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TISSUE DISTRIBUTION;

CANIS FAMILIARIS; RATTUS;

EID: 84856528894     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2011.10.018     Document Type: Article

References (21)

1. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998, 392:565-568.
2. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997, 385:640-644.
3. Combadiere C., Gao J., Tiffany H.L., Murphy P.M. Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. Biochem. Biophys. Res. Commun. 1998, 253:728-732.
4. Cotter R., Williams C., Ryan L., Erichsen D., Lopez A., Peng H., Zheng J. Fractalkine (CX3CL1) and brain inflammation: implications for HIV-1-associated dementia. J. Neurovirol. 2002, 8:585-598.
5. D'Haese J.G., Demir I.E., Friess H., Ceyhan G.O. Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. Expert Opin. Ther. Targets 2010, 14:207-219.
6. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., Raines E.W. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 2001, 276:37993-38001.
7. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997, 91:521-530.
8. Imai T., Nishimura M., Nanki T., Umehara H. Fractalkine and inflammatory diseases. Jpn. J. Clin. Immunol. 2005, 28:131-139.
9. Kobayashi T., Okamoto S., Iwakami Y., Nakazawa A., Hisamatsu T., Chinen H., Kamada N., Imai T., Goto H., Hibi T. Exclusive increase of CX3CR1+CD28-CD4+T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes. Inflamm. Bowel Dis. 2007, 13:837-846.
10. Meucci O., Fatatis A., Simen A.A., Bushell T.J., Gray P.W., Miller R.J. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14500-14505.
11. Muehlhoefer A., Saubermann L.J., Gu X., Luedtke-Heckenkamp K., Xavier R., Blumberg R.S., Podolsky D.K., MacDermott R.P., Reinecker H.C. Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J. Immunol. 2000, 164:3368-3376.
12. Nakaichi M., Taura Y., Kanki M., Mamba K., Momoi Y., Tsujimoto H., Nakama S. Establishment and characterization of a new canine B-cell leukemia cell line. J. Vet. Med. Sci. 1996, 58:469-471.
13. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., Reinecker H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 2005, 307:254-258.
14. Nishimura M., Kuboi Y., Muramoto K., Kawano T., Imai T. Chemokines as novel therapeutic targets for inflammatory bowel disease. Ann. N.Y. Acad. Sci. 2009, 1173:350-356.
15. Peters I.R., Peeters D., Helps C.R., Day M.J. Development and application of multiple internal reference (housekeeper) gene assays for accurate normalisation of canine gene expression studies. Vet. Immunol. Immunopathol. 2007, 117:55-66.
16. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 2000, 18:217-242.
17. Rossi D.L., Hardiman G., Copeland N.G., Gilbert D.J., Jenkins N., Zlotnik A., Bazan J.F. Cloning and characterization of a new type of mouse chemokine. Genomics 1998, 47:163-170.
18. Rutgen B.C., Hammer S.E., Gerner W., Christian M., de Arespacochaga A.G., Willmann M., Kleiter M., Schwendenwein I., Saalmuller A. Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma. Leuk. Res. 2010, 34:932-938.
19. Tsou C.L., Haskell C.A., Charo I.F. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J. Biol. Chem. 2001, 276:44622-44626.
20. Verge G.M., Milligan E.D., Maier S.F., Watkins L.R., Naeve G.S., Foster A.C. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur. J. Neurosci. 2004, 20:1150-1160.
21. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.